9-12-11 Daily Small Cap Market News and Stock Highlights from SmallCapVoice
Angela Moon, Reuters
Wall St cuts losses; Broadcom deal boosts Nasdaq
NEW YORK (Reuters) – U.S. stocks trimmed early losses to trade flat on Monday as European bank shares recovered and technology stocks regained their footing.
The market opened weakly with all three major indexes down more than 1 percent on worries of a credit rating downgrade of French banks and the lack of a solution to Greece's debt problem.
“The move this morning is a case of investors responding very quickly. The bottom line is that the S&P is a good global hedge, and we saw something of a recovery in European banks,” said Andrew Wilkinson, senior market analyst at Interactive Brokers Group in Greenwich, Connecticut.
The Dow Jones industrial average was down 21.60 points, or 0.20 percent, at 10,970.53. The Standard & Poor's 500 Index was up 0.16 points, or 0.01 percent, at 1,154.39. The Nasdaq Composite Index was up 11.79 points, or 0.48 percent, at 2,479.78.
Yesterday's Top Performing Small Cap Stock:
All American Gold Corp (OTCBB: AAGC )
All American Gold Corp was a SmallCapVoice.com top performer closing up over 4% on trading volume of 663,710 shares.
All American Gold Corp Announces Drilling Program to Commence on Its Goldfield West Project
All American Gold Corp (OTCBB:AAGC) is pleased to announce the commencement of the company's drilling program for its Goldfield West project in Nevada. The property is located 4 miles southwest of International Mineral's Gemfield deposit and 4.5 miles west of the Goldfield district, which is renowned for its historic production in excess of 4 million ounces of gold at an average grade of > 17 g/t Au. Drilling will target major structures which may host high-grade quartz-sulfide-gold veins similar to those in the main Goldfield district, an area where strong results have recently been announced. A total of 1,550 to 2,000 meters of RC drilling is planned for six drill sites located in both the northern and southern parts of the property.
Today's SmallCapVoice.com Hot Stock to Watch:
Jammin Java Corporation (OTCBB: JAMN )
Jammin Java Corp Issues Statement on SEC Investigation
LOS ANGELES, Sept. 09, 2011 /PRNewswire/ – As reported in recent news articles, the United States Securities & Exchange Commission (“SEC”) has been conducting a non-public and confidential inquiry in order to determine whether Jammin Java Corp (OTC Bulletin Board: JAMN) (“Jammin”), and any party affiliated or unaffiliated with Jammin, has violated the federal securities laws by participating in an unlawful “pump and dump” scheme to artificially inflate Jammin's stock price. Neither Jammin, nor anyone affiliated with the company, has participated in any “pump and dump” or other unlawful scheme designed to unlawfully inflate the company's stock. Jammin expressly repudiates any such fraudulent conduct and strongly condemns any unlawful activity.
In May 2011, Jammin became aware that unauthorized internet stock promoters were promoting short term investments in the company's stock in “stock reports” and on their websites. As stated in Jammin's May 6, 2011 Form 8-K, Jammin has no knowledge of, or affiliation with, these stock promoters. As a result, neither Jammin, nor anyone affiliated with the company, authorized, paid for or approved any stock report, advertisement or promotion of the company's stock. Any information regarding Jammin that is authorized by the company and approved for public distribution will be issued by Jammin itself through periodic filings with the SEC and/or through an authorized press release..
Other Small Cap News
IsoRay, Inc. (NYSE Amex: ISR )
FDA Clears IsoRay's GliaSite® Treatment for Brain Cancer
World's Only Liquid Radiation Balloon Catheter Device Treats Glioblastomas and Metastasized Brain Cancers
RICHLAND, Wash.–(BUSINESS WIRE)– IsoRay, Inc. (Amex:ISR) announced today that the FDA has cleared its GliaSite® radiation therapy system, a balloon catheter device used in the treatment of brain cancer. The clearance was the major step required to return the GliaSite® radiation therapy system to the marketplace. The system's balloon catheter is a landmark technology that allows physicians to treat more brain cancer patients than ever before with internal radiation or brachytherapy.
Obscene Jeans Corp. (OTCQB: OBJE )
MTV's ‘Jersey Shore' Cast Members Get Obscene
OBJE Signs Product Placement Agreement to Provide Hot New Fashions to Snooki and the Gang
SARASOTA, Fla.–(BUSINESS WIRE)– Put the kids to bed, America, because the cast of MTV's “Jersey Shore” is about to get Obscene. Obscene Jeans Corp. (OTCQB:OBJE) announced today that the company signed a product placement agreement with Celeb Branding, LLC, to outfit the female cast members of “Jersey Shore” in its hottest new fashions.
About SmallCapVoice.com
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide. Known for its ability to help emerging growth companies build a following among retail and institutional investors, SmallCapVoice.com utilizes its stock newsletter to feature its audio interviews, as well small cap company's financial news releases. SmallCapVoice.com also offers individual investors with all the tools they need to make informed decisions about the stocks they are interested in. Tools like our stock charts, stock alerts, and our company information sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets.
IMPORTANT DISCLAIMER – PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.
Contact:
Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
http://www.smallcapvoice.com
The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.
Posted-In: small cap stocksSmall Cap Analysis Trading Ideas
